Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001641172-25-005992
Filing Date
2025-04-24
Accepted
2025-04-24 15:46:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 form8a12b.htm 8-A12B 34973
2 ex4-1.htm EX-4.1 125584
3 ex10-1.htm EX-10.1 179460
  Complete submission text file 0001641172-25-005992.txt   341159
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 8-A12B | Act: 34 | File No.: 001-40101 | Film No.: 25867048
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)